Menu
← Oncology Approval Tracker
FDA DECISION ·
Jobevne
bevacizumab-nwgd · Biocon Biologics
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Avastin biosimilar for the labeled regimens in metastatic colorectal cancer, eligible nonsquamous NSCLC, recurrent glioblastoma, metastatic renal cell carcinoma, cervical cancer, and epithelial ovarian, fallopian tube, or primary peritoneal cancer.
LAMPGEN ANALYSIS
Why it matters
This anti-VEGF biosimilar adds a bevacizumab sourcing option across several solid tumor settings.
What research teams should watch
Check the precise label for each regimen and preserve product and lot traceability, blood pressure monitoring, and perioperative holds.
PRIMARY RECORDS